Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label androgen receptor antagonist. Show all posts
Showing posts with label androgen receptor antagonist. Show all posts
Wednesday, May 1, 2013

Androgen receptors found to be a potential target in breast cancer

›
In continuation of my update on Enzalutamide We know that, The androgen receptor (AR), also known as NR3C4 (nuclear receptor subfa...
Friday, October 12, 2012

FDA approves Enzalutamide (XTANDI Capsules)

›
Enzalutamide (marketed as Xtandi and formerly known as MDV3100 ) is an androgen receptor antagonist drug developed by the pharmaceu...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.